GEOVAX LABS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GEOVAX LABS, INC. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $15.00K.
- GEOVAX LABS, INC. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $37.50K, a 50.00% decline year-over-year.
- GEOVAX LABS, INC. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $137.50K, a 126.34% increase year-over-year.
- GEOVAX LABS, INC. stock issued during period, value, issued for services for the quarter ending 2023-03-31 was $75.00K.
- GEOVAX LABS, INC. stock issued during period, value, issued for services for fiscal 2023 was $212.50K, a 60.08% increase from fiscal 2022.
- GEOVAX LABS, INC. stock issued during period, value, issued for services for fiscal 2022 was $132.75K, a 84.78% increase from fiscal 2021.
- GEOVAX LABS, INC. stock issued during period, value, issued for services for fiscal 2021 was $71.84K, a 23.90% decline from fiscal 2020.
- GEOVAX LABS, INC. stock issued during period, value, issued for services for fiscal 2020 was $94.40K, a 293.33% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $15.00K S-1 · filed 2026-09-17 | |
| 2025-12-31 | $50.00K S-1 · filed 2026-09-17 | |
| 2024-12-31 | $37.50K S-1 · filed 2026-09-17 | |
| 2024-03-31 | $37.50K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $212.50K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $137.50K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $75.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $132.75K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $60.75K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $72.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $71.84K 10-K · filed 2023-03-23 | |
| 2021-06-30 | $65.84K 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $6.00K 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $94.40K 10-K · filed 2022-03-09 | |
| 2020-09-30 | $6.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $12.00K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $6.00K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $24.00K 10-K · filed 2021-03-23 | |
| 2019-09-30 | $6.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $6.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $513.50K 10-K · filed 2020-03-24 | |
| 2018-03-31 | $200.00K 10-Q · filed 2019-11-07 | |
| 2014-12-31 | $100.00K 10-K · filed 2017-03-24 | |
| 2013-12-31 | $20.50K 10-K · filed 2016-03-16 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $150.00K 10-K · filed 2014-03-14 |
| 2010-12-31 | $53.81K 10-K · filed 2014-03-14 | |
| 2009-12-31 | $31.50K 10-K · filed 2014-03-14 | |
| 2008-12-31 | $74.00K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |